Shopping Cart
Remove All
  • TargetMol
    Your shopping cart is currently empty
Filter
Applied FilterClear all
TargetMol | Tags By Target
  • AMPK
    (1)
  • Akt
    (1)
  • Apoptosis
    (1)
  • Autophagy
    (1)
  • Cysteine Protease
    (1)
  • ERK
    (1)
  • FXR
    (1)
  • GRK
    (1)
  • HCV Protease
    (1)
  • Others
    (3)
TargetMol | Tags By ResearchField
  • Immune System
    (3)
  • Inflammation
    (3)
  • Infection
    (2)
  • Nervous System
    (2)
  • Cancer
    (1)
  • Metabolism
    (1)
Filter
Search Result
Results for "

T2746

" in TargetMol Product Catalog
  • Inhibitors & Agonists
    7
    TargetMol | All_Pathways
  • Natural Products
    1
    TargetMol | Natural_Products
Sophocarpine monohydrate
Sophocarpine hydrate
T2746145572-44-7
Sophocarpine monohydrate, a major ingredient of Sophora alopecuroides, has a wide range of pharmacological effects.
  • $50
In Stock
Size
QTY
GSK2324
GSK-2324, GSK 2324
T274601020567-30-9In house
GSK2324 is a potent FXR agonist for the treatment of NAFLD by controlling hepatic lipids through reduced uptake and selective reduction of fatty acid synthesis.
  • $342
In Stock
Size
QTY
GSK-239512
GSK239512, GSK 239512
T27462720691-69-0In house
GSK-239512 is an antagonist of H3 receptor and can be used in studies about the treatment of cognitive dysfunction in neurodegenerative disorders.
  • $39
In Stock
Size
QTY
GSK270822A
GSK-270822A, GSK 270822A
T27467864082-23-5In house
GSK270822A is a selective ROCK1 inhibitor. GSK270822A exhibits IC50 of 9nM, 1100nM, 1550nM for ROCK1, RSK1, p70S6K, respectively.
  • $143
In Stock
Size
QTY
GSK2336805
JNJ-56914845, GSK-805, GSK805, GSK-2336805, GSK 2336805
T274611256390-53-0
GSK-2336805 is a HCV NS5A inhibitor. GSK2336805 retained activity on chimeric replicons containing NS5A patient sequences from genotype 1 and patient and consensus sequences for genotypes 4 and 5 and part of genotype 6.
  • $2,420
3-6 months
Size
QTY
GSK-269984B
T27466892664-17-4
GSK-269984B is a novel antagonist of EP1 receptor.
  • $1,520
6-8 weeks
Size
QTY
GSK2793660 HCl
GSK-2793660, GSK2793660, GSK 2793660
T274681613458-79-9
GSK2793660 is a irreversible covalent α,β-unsaturated amide based DPP1 inhibitor.
  • $1,520
6-8 weeks
Size
QTY